ES2083871T3 - Composicion para la aplicacion topica. - Google Patents

Composicion para la aplicacion topica.

Info

Publication number
ES2083871T3
ES2083871T3 ES93912637T ES93912637T ES2083871T3 ES 2083871 T3 ES2083871 T3 ES 2083871T3 ES 93912637 T ES93912637 T ES 93912637T ES 93912637 T ES93912637 T ES 93912637T ES 2083871 T3 ES2083871 T3 ES 2083871T3
Authority
ES
Spain
Prior art keywords
composition
melanine
added
topical use
light protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93912637T
Other languages
English (en)
Inventor
Udo Gross
Leonhard Zastrow
Joachim Roding
Klaus Stanzl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lancaster Group AG
Original Assignee
Lancaster Group AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lancaster Group AG filed Critical Lancaster Group AG
Application granted granted Critical
Publication of ES2083871T3 publication Critical patent/ES2083871T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UNA COMPOSICION PARA UTILIZACION TOPICA CON PROPIEDADES DE PROTECCION DE LUZ EN UNA FORMA DE APLICACION ESPECIAL. EL PROBLEMA CON LOS AGENTES DE PROTECCION DE LUZ CONOCIDOS CONTENIENDO MELANINA ACTIVA COMO SUSTANCIA ACTIVA ES UN TRANSPORTE DE MELANINA INSUFICIENTE AL LUGAR DE ACTIVIDAD. LA INVENCION RESUELVE EL PROBLEMA CON UNA COMPOSICION DE UTILIZACION TOPICA CARACTERIZADA POR UN CONTENIDO EN MELANINA DISUELTO O DISPERSO EN UNO O VARIOS FLUORCARBONOS DISPONIBLES COMO AGREGADOS FOSFOLIPIDOS LAMINADOS DE FORMA ASIMETRICA EN UN SISTEMA ACUOSO, CONJUNTAMENTE CON UN FOSFOLIPIDO. EL TAMAÑO DE PARTICULA DEL AGREGADO SE ENCUENTRA EN LA ZONA DESDE 200 A 3.000 NM.
ES93912637T 1992-06-26 1993-06-24 Composicion para la aplicacion topica. Expired - Lifetime ES2083871T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221269A DE4221269C1 (de) 1992-06-26 1992-06-26 Zubereitung zur topischen Anwendung

Publications (1)

Publication Number Publication Date
ES2083871T3 true ES2083871T3 (es) 1996-04-16

Family

ID=6462056

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93912637T Expired - Lifetime ES2083871T3 (es) 1992-06-26 1993-06-24 Composicion para la aplicacion topica.

Country Status (20)

Country Link
EP (1) EP0647129B1 (es)
JP (1) JP3599113B2 (es)
AT (1) ATE131031T1 (es)
AU (1) AU671645B2 (es)
CA (1) CA2138975C (es)
CZ (1) CZ283659B6 (es)
DE (2) DE4221269C1 (es)
DK (1) DK0647129T3 (es)
ES (1) ES2083871T3 (es)
FI (1) FI946057L (es)
GR (1) GR3018337T3 (es)
HK (1) HK1002701A1 (es)
HU (1) HUT68858A (es)
IL (1) IL105947A (es)
NO (1) NO303666B1 (es)
NZ (1) NZ253000A (es)
PL (1) PL172360B1 (es)
SK (1) SK279823B6 (es)
WO (1) WO1994000097A1 (es)
ZA (1) ZA934573B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643554A (en) * 1993-04-30 1997-07-01 Dusa Pharmaceuticals, Inc. Lipomelanim composition
DE4443243C2 (de) * 1994-11-24 1998-02-19 Lancaster Group Gmbh Sonnenschutzzubereitung mit erhöhtem Lichtschutzfaktor
US6303106B1 (en) * 1995-12-07 2001-10-16 Zylepsis Limited Allomelanin production
RU2143263C1 (ru) * 1998-08-06 1999-12-27 Махлис Леонид Абрамович Эмульсия перфторуглеродов для косметических и/или дерматологических препаратов
US6321335B1 (en) 1998-10-30 2001-11-20 Acqis Technology, Inc. Password protected modular computer method and device
US6311268B1 (en) 1998-11-06 2001-10-30 Acqis Technology, Inc. Computer module device and method for television use
US6643777B1 (en) 1999-05-14 2003-11-04 Acquis Technology, Inc. Data security method and device for computer modules
US6718415B1 (en) 1999-05-14 2004-04-06 Acqis Technology, Inc. Computer system and method including console housing multiple computer modules having independent processing units, mass storage devices, and graphics controllers
US7990724B2 (en) 2006-12-19 2011-08-02 Juhasz Paul R Mobile motherboard
RU2381792C2 (ru) * 2008-04-02 2010-02-20 Закрытое акционерное общество "Лаборатория Низар-А" Средство для мезотерапии

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2010445A6 (es) * 1988-03-11 1989-11-01 Alpha Therapeutic Corp Emulsion perfluoroquimica estable y metodo para su produccion.
AU5195090A (en) * 1989-03-07 1990-10-09 Plough Inc. Liposome compositions
AU647372B2 (en) * 1989-07-05 1994-03-24 Alliance Pharmaceutical Corporation Fluorocarbon emulsions having saturated phospholipid emulsifiers
DE4127442C2 (de) * 1991-08-17 1996-08-22 Udo Dr Gros Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
AU671645B2 (en) 1996-09-05
DE59301120D1 (de) 1996-01-18
AU4307993A (en) 1994-01-24
IL105947A (en) 1997-07-13
DE4221269C1 (de) 1993-12-09
JPH07508007A (ja) 1995-09-07
FI946057A7 (fi) 1994-12-23
JP3599113B2 (ja) 2004-12-08
CZ283659B6 (cs) 1998-05-13
DK0647129T3 (da) 1996-01-08
HUT68858A (en) 1995-08-28
EP0647129A1 (de) 1995-04-12
HU9403736D0 (en) 1995-02-28
FI946057A0 (fi) 1994-12-23
ZA934573B (en) 1994-01-31
FI946057L (fi) 1994-12-23
CA2138975C (en) 2003-05-13
PL172360B1 (en) 1997-09-30
NZ253000A (en) 1997-05-26
NO303666B1 (no) 1998-08-17
ATE131031T1 (de) 1995-12-15
SK279823B6 (sk) 1999-04-13
NO944956L (no) 1994-12-21
NO944956D0 (no) 1994-12-21
WO1994000097A1 (de) 1994-01-06
SK156694A3 (en) 1995-07-11
GR3018337T3 (en) 1996-03-31
HK1002701A1 (en) 1998-09-11
EP0647129B1 (de) 1995-12-06
CZ326894A3 (en) 1995-09-13
IL105947A0 (en) 1993-10-20
CA2138975A1 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
ES2104797T3 (es) Composiciones farmaceuticas con actividad antagonista de angiotensina-ii.
ES2083871T3 (es) Composicion para la aplicacion topica.
ES2054069T3 (es) Composicion cosmetica o farmaceutica que contiene microesferas de polimeros o de cuerpos grasos cargados de al menos un producto activo.
ES2180938T3 (es) Donadores de oxido nitrico capaces de reducir la toxicidad de los farmacos.
GT199700089A (es) Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
CO4560552A1 (es) Antagonistas de receptores de taquicininas no peptidicos
AR002007A1 (es) UNA COMPOSICION TERAPEUTICA DE APLICACION TOPICA QUE CONTIENE UN ANTAGONISTA DE SUSTANCIA P Y UTILIZACION DE DICHO ANTAGONISTA PARA LAPREPARACIóN DE DICHA COMPOSICION PARA DISMINUIR Y/O ELIMINAR UN EFECTO SECUNDARIO IRRITANTE DE UN PRODUCTO CONTENIDO EN LA MISMA.
ES8608875A1 (es) Un metodo para preparar una composicion farmaceutica para aplicacion topica que contiene 1-dodecilazacicloheptan-2-ona.
ES2097787T5 (es) Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon.
AR006308A1 (es) Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.
CO5050328A1 (es) Sistema solvente para la mejor penetracion de compuestos farmaceuticos
GT199600051A (es) Metanolsulfonato de (1s, 2s)-1- (4-hidroxifenil)-2-(4-hidroxi-4- fenilpiperidin-1-il)-1-propanol trihidrato.
MX9304015A (es) Antagonistas de oxitoxina.
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
AR000509A1 (es) Utilización de un antagonist de sustancia p para la preparación de una composición farmacéutica paratratar algunas enfermedades de la piel de origen neurogeno
BRPI0504445A (pt) composição de trombina e processo para a sua preparação
ES2092646T3 (es) Metanoantracenos como antagonistas de dopamina.
AR000357A1 (es) Utilización de un antagonista de sustancia p para la preparación de una composición farmacéutica de aplicación topica para tratar las manchas rojas cutaneas de origen neurogeno y especialmente la rosacea y el eritema pudico
BR9908427A (pt) Composições farmacêuticas e uso das mesmas
ES8700049A1 (es) Un procedimiento para la preparacion de una composicion topica para reducir la secrecion de sebo
MX9203739A (es) Complejo organico de oro aplicado topicamente.
ES2192779T3 (es) Modificacion cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida y su uso como antiepileptico.
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
AR021463A1 (es) Antibiotico de piridona con perfil de seguridad mejorado
ES2092645T3 (es) Metanoantracenos como antagonistas de dopamina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 647129

Country of ref document: ES